Literature DB >> 20075203

EML4-ALK fusion in lung.

Hiroyuki Mano, Kengo Takeuchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20075203      PMCID： PMC2832173          DOI： 10.2353/ajpath.2010.091057

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  12 in total

1.  The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells.

Authors:  B Maes; V Vanhentenrijk; I Wlodarska; J Cools; B Peeters; P Marynen; C de Wolf-Peeters
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

2.  EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues.

Authors:  Maria Paola Martelli; Gabriella Sozzi; Luis Hernandez; Valentina Pettirossi; Alba Navarro; Davide Conte; Patrizia Gasparini; Federica Perrone; Piergiorgio Modena; Ugo Pastorino; Antonino Carbone; Alessandra Fabbri; Angelo Sidoni; Shigeo Nakamura; Marcello Gambacorta; Pedro Luis Fernández; Jose Ramirez; John K C Chan; Walter Franco Grigioni; Elias Campo; Stefano A Pileri; Brunangelo Falini
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

3.  KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer.

Authors:  Kengo Takeuchi; Young Lim Choi; Yuki Togashi; Manabu Soda; Satoko Hatano; Kentaro Inamura; Shuji Takada; Toshihide Ueno; Yoshihiro Yamashita; Yukitoshi Satoh; Sakae Okumura; Ken Nakagawa; Yuichi Ishikawa; Hiroyuki Mano
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

4.  Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.

Authors:  Young Lim Choi; Kengo Takeuchi; Manabu Soda; Kentaro Inamura; Yuki Togashi; Satoko Hatano; Munehiro Enomoto; Toru Hamada; Hidenori Haruta; Hideki Watanabe; Kentaro Kurashina; Hisashi Hatanaka; Toshihide Ueno; Shuji Takada; Yoshihiro Yamashita; Yukihiko Sugiyama; Yuichi Ishikawa; Hiroyuki Mano
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

5.  Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.

Authors:  Kengo Takeuchi; Young Lim Choi; Manabu Soda; Kentaro Inamura; Yuki Togashi; Satoko Hatano; Munehiro Enomoto; Shuji Takada; Yoshihiro Yamashita; Yukitoshi Satoh; Sakae Okumura; Ken Nakagawa; Yuichi Ishikawa; Hiroyuki Mano
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

6.  Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.

Authors:  Scott J Rodig; Mari Mino-Kenudson; Sanja Dacic; Beow Y Yeap; Alice Shaw; Justine A Barletta; Hannah Stubbs; Kenny Law; Neal Lindeman; Eugene Mark; Pasi A Janne; Thomas Lynch; Bruce E Johnson; A John Iafrate; Lucian R Chirieac
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

7.  MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.

Authors:  Michèle Beau-Faller; Anne-Marie Ruppert; Anne-Claire Voegeli; Agnès Neuville; Nicolas Meyer; Eric Guerin; Michèle Legrain; Bertrand Mennecier; Jean-Marie Wihlm; Gilbert Massard; Elisabeth Quoix; Pierre Oudet; Marie P Gaub
Journal:  J Thorac Oncol       Date:  2008-04       Impact factor: 15.609

8.  Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Authors:  Manabu Soda; Young Lim Choi; Munehiro Enomoto; Shuji Takada; Yoshihiro Yamashita; Shunpei Ishikawa; Shin-ichiro Fujiwara; Hideki Watanabe; Kentaro Kurashina; Hisashi Hatanaka; Masashi Bando; Shoji Ohno; Yuichi Ishikawa; Hiroyuki Aburatani; Toshiro Niki; Yasunori Sohara; Yukihiko Sugiyama; Hiroyuki Mano
Journal:  Nature       Date:  2007-07-11       Impact factor: 49.962

9.  EML4-ALK fusion lung cancer: a rare acquired event.

Authors:  Sven Perner; Patrick L Wagner; Francesca Demichelis; Rohit Mehra; Christopher J Lafargue; Benjamin J Moss; Stefanie Arbogast; Alex Soltermann; Walter Weder; Thomas J Giordano; David G Beer; David S Rickman; Arul M Chinnaiyan; Holger Moch; Mark A Rubin
Journal:  Neoplasia       Date:  2008-03       Impact factor: 5.715

10.  Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.

Authors:  Klarisa Rikova; Ailan Guo; Qingfu Zeng; Anthony Possemato; Jian Yu; Herbert Haack; Julie Nardone; Kimberly Lee; Cynthia Reeves; Yu Li; Yerong Hu; Zhiping Tan; Matthew Stokes; Laura Sullivan; Jeffrey Mitchell; Randy Wetzel; Joan Macneill; Jian Min Ren; Jin Yuan; Corey E Bakalarski; Judit Villen; Jon M Kornhauser; Bradley Smith; Daiqiang Li; Xinmin Zhou; Steven P Gygi; Ting-Lei Gu; Roberto D Polakiewicz; John Rush; Michael J Comb
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582
View more
  4 in total

Review 1.  ALK-immunoreactive neoplasms.

Authors:  Parham Minoo; Huan-You Wang
Journal:  Int J Clin Exp Pathol       Date:  2012-05-23

2.  SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway.

Authors:  Qiao-Yang Sun; Ling-Wen Ding; Jin-Fen Xiao; Wenwen Chien; Su-Lin Lim; Norimichi Hattori; Lee Goodglick; David Chia; Vei Mah; Mohammad Alavi; Sara R Kim; Ngan B Doan; Jonathan W Said; Xin-Yi Loh; Liang Xu; Li-Zhen Liu; Henry Yang; Takahide Hayano; Shuo Shi; Dong Xie; De-Chen Lin; H Phillip Koeffler
Journal:  J Pathol       Date:  2014-12-18       Impact factor: 7.996

Review 3.  Molecular Pathology and Personalized Medicine: The Dawn of a New Era in Companion Diagnostics-Practical Considerations about Companion Diagnostics for Non-Small-Cell-Lung-Cancer.

Authors:  Till Plönes; Walburga Engel-Riedel; Erich Stoelben; Christina Limmroth; Oliver Schildgen; Verena Schildgen
Journal:  J Pers Med       Date:  2016-01-15

4.  [Methylation Status of the SOCS3 Gene Promoter in H2228 Cells and 
EML4-ALK-positive Lung Cancer Tissues].

Authors:  Chunlai Liu; Yongwen Li; Yunlong Dong; Hongbing Zhang; Ying Li; Hongyu Liu; Jun Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-09-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.